The Clorox Company (NYSE:CLX) Shares Sold by Burns J W & Co. Inc. NY

Burns J W & Co. Inc. NY decreased its position in shares of The Clorox Company (NYSE:CLX) by 0.8% during the 1st quarter, HoldingsChannel reports. The fund owned 10,226 shares of the company’s stock after selling 83 shares during the quarter. Burns J W & Co. Inc. NY’s holdings in Clorox were worth $1,566,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the company. Fortitude Family Office LLC purchased a new position in shares of Clorox during the 4th quarter worth $29,000. Northwest Financial Advisors acquired a new position in shares of Clorox in the 4th quarter worth approximately $29,000. Core Wealth Advisors Inc. purchased a new position in shares of Clorox during the 4th quarter worth approximately $29,000. First United Bank & Trust acquired a new stake in Clorox in the 4th quarter valued at approximately $31,000. Finally, GoalVest Advisory LLC purchased a new stake in Clorox in the first quarter valued at approximately $31,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 0.1 %

Shares of NYSE CLX traded down $0.13 during mid-day trading on Friday, reaching $136.47. The company had a trading volume of 1,667,373 shares, compared to its average volume of 1,254,727. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.14. The stock has a market cap of $16.95 billion, a P/E ratio of 70.72, a PEG ratio of 2.19 and a beta of 0.39. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The firm has a 50 day simple moving average of $136.95 and a two-hundred day simple moving average of $143.79.

Clorox (NYSE:CLX) last posted its earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. The business had revenue of $1.81 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The business’s revenue was down 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.51 earnings per share. Sell-side analysts predict that The Clorox Company will post 5.91 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. dropped their price objective on Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Morgan Stanley reissued an “equal weight” rating and set a $160.00 price target on shares of Clorox in a research report on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Argus raised shares of Clorox to a “hold” rating in a research report on Tuesday, June 4th. Finally, Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective on the stock in a research report on Tuesday, March 26th. Five equities research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $145.33.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.